X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (139) 139
humans (133) 133
oncology (109) 109
male (58) 58
female (55) 55
middle aged (54) 54
cancer (50) 50
aged (48) 48
adult (42) 42
chemotherapy (34) 34
medicine, general & internal (32) 32
treatment outcome (29) 29
aged, 80 and over (25) 25
antineoplastic combined chemotherapy protocols - therapeutic use (25) 25
colorectal neoplasms - drug therapy (25) 25
prognosis (23) 23
clinical trials (22) 22
colorectal cancer (22) 22
care and treatment (21) 21
australia (20) 20
antineoplastic agents - therapeutic use (19) 19
disease-free survival (19) 19
hematology, oncology and palliative medicine (19) 19
survival (19) 19
surgery (18) 18
pharmacology & pharmacy (17) 17
fluorouracil (16) 16
fluorouracil - administration & dosage (16) 16
quality of life (16) 16
research (16) 16
therapy (16) 16
cetuximab (15) 15
oxaliplatin (15) 15
patients (15) 15
tumors (14) 14
antineoplastic combined chemotherapy protocols - adverse effects (13) 13
leucovorin (13) 13
survival rate (13) 13
bevacizumab (12) 12
drug therapy (12) 12
medical research (12) 12
neoplasm staging (12) 12
abridged index medicus (11) 11
analysis (11) 11
metastasis (11) 11
neoplasm metastasis (11) 11
tumor cells, cultured (11) 11
antineoplastic combined chemotherapy protocols - administration & dosage (10) 10
colorectal neoplasms - pathology (10) 10
gastrointestinal stromal tumors - drug therapy (10) 10
imatinib mesylate (10) 10
medicine & public health (10) 10
neoplasms - drug therapy (10) 10
patient outcomes (10) 10
adenocarcinoma (9) 9
animals (9) 9
antibodies, monoclonal - therapeutic use (9) 9
chemotherapy, adjuvant (9) 9
colorectal neoplasms - genetics (9) 9
diagnosis (9) 9
imatinib (9) 9
leucovorin - administration & dosage (9) 9
management (9) 9
neoplasms - therapy (9) 9
radiotherapy (9) 9
adenocarcinoma - pathology (8) 8
adjuvant treatment (8) 8
antineoplastic agents - administration & dosage (8) 8
cancer research (8) 8
carcinoma (8) 8
dose-response relationship, drug (8) 8
drug administration schedule (8) 8
efficacy (8) 8
expression (8) 8
gastric cancer (8) 8
kaplan-meier estimate (8) 8
mutation (8) 8
mutations (8) 8
neoadjuvant therapy (8) 8
phase-ii (8) 8
safety (8) 8
survival analysis (8) 8
trial (8) 8
young adult (8) 8
adenocarcinoma - drug therapy (7) 7
adjuvant chemotherapy (7) 7
benzamides (7) 7
cancer therapies (7) 7
clinical-trials (7) 7
colorectal neoplasms - mortality (7) 7
disease progression (7) 7
gastroenterology & hepatology (7) 7
hematology (7) 7
irinotecan (7) 7
kit (7) 7
medicine, experimental (7) 7
metastases (7) 7
monoclonal antibodies (7) 7
neoplasms (7) 7
neoplasms - psychology (7) 7
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 08/2018, Volume 379, Issue 7, pp. 694 - 695
To the Editor: Lyman and colleagues (May 24 issue)1 discuss the benefits of biosimilar medications for the health care system. I would like to highlight... 
Medical research | Epidermal growth factor | Oncology | Lymphomas | Breast cancer | Clinical medicine | FDA approval | Cancer therapies | ErbB-2 protein | Gastric cancer | Trastuzumab
Journal Article
Seminars in Oncology, ISSN 0093-7754, 10/2017, Volume 44, Issue 5, pp. 372 - 373
Journal Article
Cancer Research, ISSN 0008-5472, 2016, Volume 51, Issue 6, p. 1750
Journal Article
NEW ENGLAND JOURNAL OF MEDICINE, ISSN 0028-4793, 08/2018, Volume 379, Issue 7, pp. 694 - 694
Journal Article
SEMINARS IN ONCOLOGY, ISSN 0093-7754, 10/2017, Volume 44, Issue 5, pp. 372 - 373
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2008, Volume 359, Issue 17, pp. 1757 - 1765
Journal Article
Medical Journal of Australia, ISSN 0025-729X, 10/2018, Volume 209, Issue 10, pp. 424 - 425.e1
Engaging clinicians in the process of trial design, and the ensuing dialogue about best practice, can improve routine care 
Environment and public health | Statistics, epidemiology and research design | Evidence-based medicine | Clinical trials as topic | Public health | SURVIVAL | MEDICINE, GENERAL & INTERNAL | OUTCOMES | LESSONS | CANCER | CHEMOTHERAPY | CARE
Journal Article
Medical Journal of Australia, ISSN 0025-729X, 08/2018, Volume 209, Issue 4, pp. 187 - 187.e1
Journal Article
BMJ-BRITISH MEDICAL JOURNAL, ISSN 1756-1833, 04/2019, Volume 365, pp. l1720 - l1720
Journal Article
Internal Medicine Journal, ISSN 1444-0903, 10/2017, Volume 47, Issue 10, pp. 1197 - 1199
Journal Article
Journal Article
Medical Journal of Australia, ISSN 0025-729X, 09/2014, Volume 201, Issue 6, pp. 347 - 349
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 07/2010, Volume 28, Issue 19, pp. 3191 - 3198
Journal Article
JAMA, ISSN 0098-7484, 10/2010, Volume 304, Issue 16, pp. 1812 - 1820
Journal Article
Cancer Forum, ISSN 0311-306X, 2014, Volume 38, Issue 1, pp. 44 - 52
Journal Article
Asia-Pacific Journal of Clinical Oncology, ISSN 1743-7555, 12/2014, Volume 10, Issue 4, pp. 378 - 380
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2018, Volume 379, Issue 7, pp. 694 - 695
To the Editor: Lyman and colleagues (May 24 issue) 1 discuss the benefits of biosimilar medications for the health care system. I would like to highlight... 
MEDICINE, GENERAL & INTERNAL | Index Medicus | Abridged Index Medicus
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.